Form 8-K - Current report:
SEC Accession No. 0000891020-05-000248
Filing Date
2005-09-01
Accepted
2005-09-01 17:23:37
Documents
5
Period of Report
2005-09-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v12270e8vk.htm 8-K 15681
2 EXHIBIT 10.1 v12270exv10w1.txt EX-10.1 23412
3 EXHIBIT 10.2 v12270exv10w2.txt EX-10.2 3567
4 EXHIBIT 10.3 v12270exv10w3.txt EX-10.3 4830
5 EXHIBIT 99.1 v12270exv99w1.txt EX-99.1 4780
  Complete submission text file 0000891020-05-000248.txt   53819
Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23930 | Film No.: 051065476
SIC: 2836 Biological Products, (No Diagnostic Substances)